Items where Author is "Haen, E."
 | Up a level |
Article
Weisser, R. and Jalili, S. and Haen, E. and Schulte-Mattler, W. and Wetter, T. C. (2019) Rhabdomyolysis under treatment with venlafaxine and risperidone. NERVENARZT, 91 (2). pp. 153-155. ISSN 0028-2804, 1433-0407
Unholzer, S. and Rothmund, A. and Haen, E. (2017) All-rounder vitamin D? NERVENARZT, 88 (5). pp. 489-494. ISSN 0028-2804, 1433-0407
Wolf, L. and Bauer, A. and Melchner, D. and Hallof-Buestrich, H. and Stoertebecker, P. and Haen, E. and Kreutz, M. and Sarubin, N. and Milenkovic, V. M. and Wetzel, C. H. and Rupprecht, R. and Nothdurfter, C. (2015) Enhancing Neurosteroid Synthesis - Relationship to the Pharmacology of Translocator Protein (18 kDa) (TSPO) Ligands and Benzodiazepines. PHARMACOPSYCHIATRY, 48 (2). pp. 72-77. ISSN 0176-3679, 1439-0795
Unholzer, S. and Haen, E. (2015) Retrospective Analysis of Therapeutic Drug Monitoring Data for Treatment of Bipolar Disorder with Lamotrigine. PHARMACOPSYCHIATRY, 48 (6). pp. 211-214. ISSN 0176-3679, 1439-0795
Sigurdsson, H. P. and Hefner, G. and Ben-Omar, N. and Koestlbacher, A. and Wenzel-Seifert, K. and Hiemke, C. and Haen, E. (2015) Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI. JOURNAL OF NEURAL TRANSMISSION, 122 (5). pp. 721-729. ISSN 0300-9564, 1435-1463
Haen, E. (2014) Drug-drug interactions. Interactions between xenobiotics. NERVENARZT, 85 (4). 417-+. ISSN 0028-2804, 1433-0407
Wenzel-Seifert, K. and Brandl, R. and Hiemke, C. and Haen, E. (2014) Influence of Concomitant Medications on the Total Clearance and the Risk for Supra-therapeutic Plasma Concentrations of Citalopram. A Population-Based Cohort Study. PHARMACOPSYCHIATRY, 47 (7). pp. 239-244. ISSN 0176-3679, 1439-0795
Babl, M. and Wenzel-Seifert, K. and Haen, E. (2012) Age- and sex-dependency of psychotropic drug induced hyperprolactinemia. PHARMACOPSYCHIATRY, 45 (6): A1. p. 251. ISSN 0176-3679
Ben-Omar, N. and Wenzel-Seifert, K. and Haen, E. (2012) Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions. PHARMACOPSYCHIATRY, 45 (6): A4. p. 252. ISSN 0176-3679
Wolf, M. and Koepp, A. and Doerfelt, A. and Haen, E. (2012) Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6-HPLC as a quantitative method for analysis in TDM. PHARMACOPSYCHIATRY, 45 (6): A27. p. 257. ISSN 0176-3679
Unterecker, S. and Hiemke, C. and Greiner, C. and Haen, E. and Jabs, B. and Deckert, J. and Pfuhlmann, B. (2012) The Effect of Age, Sex, Smoking and Co-Medication on Serum Levels of Venlafaxine and O-Desmethylvenlafaxine under Naturalistic Conditions. PHARMACOPSYCHIATRY, 45 (6). pp. 229-235. ISSN 0176-3679, 1439-0795
Brandl, R. and Koeber, R. and Jahner, T. and Outlaw, E. M. and Wenzel-Seifert, K. and Wittmann, K. and Haen, E. (2012) Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine. PHARMACOPSYCHIATRY, 45 (6): A5. p. 252. ISSN 0176-3679
Koeppl, A. and Melchner, D. and Haen, E. (2012) Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) - and HPLC and UV-detection. PHARMACOPSYCHIATRY, 45 (6): A12. p. 254. ISSN 0176-3679
Ben-Omar, N. and Jahner, T. and Melchner, D. and Haen, E. (2012) Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV. PHARMACOPSYCHIATRY, 45 (6): A3. p. 251. ISSN 0176-3679
Onuoha, M. R. and Haen, E. (2012) The frequency and cost comparison of haloperidol prescriptions - haloperidol data analysis from therapeutic drug monitoring 2006-2011. PHARMACOPSYCHIATRY, 45 (6): A16. p. 255. ISSN 0176-3679
Hiemke, C. and Baumann, P. and Bergemann, N. and Conca, A. and Dietmaier, O. and Egberts, K. and Fric, M. and Gerlach, M. and Greiner, C. and Gruender, G. and Haen, E. and Havemann-Reinecke, U. and Sirot, E. Jaquenoud and Kirchherr, H. and Laux, G. and Lutz, U. C. and Messer, T. and Mueller, M. J. and Pfuhlmann, B. and Rambeck, B. and Riederer, P. and Schoppek, B. and Stingl, J. and Uhr, M. and Ulrich, S. and Waschgler, R. and Zernig, G. (2011) AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011. PHARMACOPSYCHIATRY, 44 (6). pp. 195-235. ISSN 0176-3679, 1439-0795
Unterecker, S. and Pfuhlmann, B. and Hiemke, C. and Greiner, C. and Haen, E. and Jabs, B. and Kruggel-Bachmann, S. and Deckert, J. (2011) Additive effects of sex, age and smoking on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions. PHARMACOPSYCHIATRY, 44 (6): 21 - A17. ISSN 0176-3679
Wenzel-Seifert, K. and Wittmann, M. and Koestlbacher, A. and Haen, E. (2011) Analysis of TDM data of clozapine: A daily consumption of less than 10 cigarettes is sufficient for maximum induction of clozapine metabolism. PHARMACOPSYCHIATRY, 44 (6): 21 - A20. ISSN 0176-3679
Neuner, Tanja and Huebner-Liebermann, B. and Haen, E. and Hausner, H. and Felber, W. and Wittmann, M. (2011) Completed Suicides in 47 Psychiatric Hospitals in Germany - Results from the AGATE-Study. PHARMACOPSYCHIATRY, 44 (7). pp. 324-330. ISSN 0176-3679
Onuoha, M. and Outlaw, E. and Doerfelt, A. and Jahner, T. and Melchner, D. and Haen, E. (2011) Determination of phenothiazine concentration in serum - The importance of a suitable column. PHARMACOPSYCHIATRY, 44 (6): 21 - A83. ISSN 0176-3679
Wenzel-Seifert, K. and Koestlbacher, A. and Haen, E. (2011) Dose-dependent effects of cigarette smoking on serum concentrations of psychotropic drugs. THERAPEUTIC DRUG MONITORING, 33 (4). pp. 481-482. ISSN 0163-4356
Brandl, R. and Koeber, R. and Jahner, T. and Doerfelt, A. and Melchner, D. and Haen, E. (2011) ENZYME ASSAY TO STUDY THE METABOLISM OF QUETIAPINE AND THE INFLUENCE OF CITALOPRAME, VENLAFAXINE AND MIRTAZAPINE AS PSYCHOTROPIC COMEDICATION. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 72 (s1). p. 7. ISSN 0306-5251
Brandl, R. and Koeber, R. and Jahner, T. and Doerfelt, A. and Haen, E. (2011) Enzyme assay to study the influence of citalopram on the concentration of psychotropic comedication. PHARMACOPSYCHIATRY, 44 (6): 21 - A4. ISSN 0176-3679
Brandl, R. and Jahner, T. and Wenzel-Seifert, K. and Doerfelt, A. and Wittmann, M. and Haen, E. (2011) Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication. THERAPEUTIC DRUG MONITORING, 33 (4). p. 526. ISSN 0163-4356
Brandl, R. and Koeber, R. and Jahner, T. and Outlaw, E. and Wittmann, M. and Haen, E. (2011) Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine. PHARMACOPSYCHIATRY, 44 (6): 21 - A10. ISSN 0176-3679
Haen, E. and Koestlbacher, A. (2011) THE INTERNET PLATFORM KONBEST - A TOOL FOR THERAPEUTIC DRUG MONITORING (TDM) TO INDIVIDUALIZE DOSING. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 72 (s1). p. 8. ISSN 0306-5251
Hader, A. and Beck, S. and Jahner, T. and Melchner, D. and Haen, E. (2011) Identification of a slow CYP3A4 metabolizer by TDM - a case report. PHARMACOPSYCHIATRY, 44 (6): 21 - A18. ISSN 0176-3679
Koestlbacher, A. and Hiemke, C. and Haen, E. (2011) Information search and software use in TDM laboratories - a survey. PHARMACOPSYCHIATRY, 44 (6): 21 - A22. ISSN 0176-3679
Wenzel-Seifert, K. and Wittmann, M. and Haen, E. (2011) Sex- and age-dependency of haematological adverse reactions associated with psychotropic drugs: Analysis of the data bank of the drug safety program for psychiatric disorders AGATE. PHARMACOPSYCHIATRY, 44 (6): 21 - A118. ISSN 0176-3679
Plattner, B. and Koestlbacher, A. and Conca, A. and Haen, E. (2011) TDM case report as example for clinical pharmacological commenting by means of the internet platform Konbest. PHARMACOPSYCHIATRY, 44 (6): 21 - A89. ISSN 0176-3679
Schmid, K. and Melchner, D. and Doerfelt, A. and Haen, E. (2011) THERAPEUTIC DRUG MONITORING (TDM) WITH UHPLC - AN ALTERNATIVE TO HPLC AND LC/MS RESPECTIVELY? BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 72 (s1). p. 31. ISSN 0306-5251
Koeber, R. and Kluenemann, H-H and Waimer, R. and Koestlbacher, A. and Doerfelt, A. and Melchner, D. and Haen, E. (2011) THERAPEUTIC DRUG MONITORING OF ANTIDEMENTIA DRUGS. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 72 (s1). p. 9. ISSN 0306-5251
Haen, E. (2011) Therapeutic Drug Monitoring in Pharmacovigilance and Pharmacotherapy Safety. PHARMACOPSYCHIATRY, 44 (6). pp. 254-258. ISSN 0176-3679
Ben Omar, N. and Jahner, T. and Doerfelt, A. and Melchner, D. and Koestlbacher, A. and Haen, E. (2011) Therapeutic drug monitoring of fluoxetine, desmethylfluoxetine, sertraline and desmethylsertraline using column switching HPLC. PHARMACOPSYCHIATRY, 44 (6): 21 - A8. ISSN 0176-3679
Ben Omar, N. A. and Jahner, T. and Doerfelt, A. and Melchner, D. and Haen, E. (2011) Therapeutic drug monitoring of selective serotonin reuptake inhibitors using column switchig HPLC. THERAPEUTIC DRUG MONITORING, 33 (4). pp. 526-527. ISSN 0163-4356
Haen, E. and Koestlbacher, A. and Bader, W. and Greiner, C. and Hader, A. and Koeber, R. and Wenzel-Seifert, K. and Wittmann, M. and Doerfelt, A. and Melchner, D. and Outlaw, E. and Brandl, R. (2011) The dose-related reference range - a new tool for therapeutic drug monitoring (TDM). PHARMACOPSYCHIATRY, 44 (6): 21 - A48. ISSN 0176-3679
Wittmann, M. and Koestlbacher, A. and Hader, A. and Koeber, R. and Haen, E. (2011) The impact of metabolic pathways to drug-drug interactions. PHARMACOPSYCHIATRY, 44 (6): 21 - A122. ISSN 0176-3679
Hehl, R. and Beck, S. and Jahner, T. and Melchner, D. and Haen, E. (2011) A method for automated quantitative analysis of bupropion and its major metabolites in serum by high performance liquid chromatography (HPLC). PHARMACOPSYCHIATRY, 44 (6): 21 - A1. ISSN 0176-3679
Fischer-Barnicol, D. and Koch, H. and Lanquillon, S. and Haen, E. and Leucht, S. and Stoppe, G. (2010) THE RELEVANCE OF DOSES FOR COMPARING HALOPERIDOL, RISPERIDONE AND OLANZAPINE. EUROPEAN PSYCHIATRY, 25 (Suppl1). p. 992. ISSN 0924-9338
Wenzel-Seifert, K. and Wittmann, M. and Haen, E. (2010) Torsade de Pointes Episodes under Treatment with Selective Serotonin Reuptake Inhibitors. PHARMACOPSYCHIATRY, 43 (7). pp. 279-281. ISSN 0176-3679
Haen, E. and Greiner, C. and Bader, W. and Wittmann, M. (2008) Expanding therapeutic reference ranges using dose-related reference ranges. NERVENARZT, 79 (5). pp. 558-566. ISSN 0028-2804
Hader, A. and Melchner, D. and Kirchheiner, J. and Haen, E. (2008) Genotyping in the TDM Laboratory - Necessary for Pharmacovigilance? DRUG SAFETY, 31 (10). pp. 908-909. ISSN 0114-5916
Bader, Wolfgang and Greiner, C. and Haen, E. (2008) Increase of risperidone concentraton under chlorprothixene comedication - A case report. PHARMACOPSYCHIATRY, 41 (3). pp. 116-117. ISSN 0176-3679
Koeber, R. and Kluenemann, H. H. and Melchner, D. and Haen, E. (2008) Therapeutic Drug Monitoring of Antidementia Drugs: A Valid Tool for Successful Individual Benefit/Risk Evaluation. DRUG SAFETY, 31 (10). pp. 902-903. ISSN 0114-5916
Hausner, Helmut and Wittmann, M. and Haen, E. and Spiessl, H. (2008) The untreated patients: Depression in elderly men. NERVENHEILKUNDE, 27 (7). pp. 617-619. ISSN 0722-1541
Haen, E. (2007) Clinical pharmacology of analgesics. ORTHOPADE, 36 (1). pp. 17-22. ISSN 0085-4530
Koeber, Ralf and Bader, W. and Jahner, T. and Melchner, D. and Haen, E. (2007) Determination of Galantamin from Serum under application of solid phase pre-extraction and HPLC-UV-detection technics in the medical routine analytic. NERVENARZT, 78 (Suppl2). p. 137. ISSN 0028-2804
Koeber, R. and Bader, W. and Jahner, T. and Melchner, D. and Haen, E. (2007) Determination of rivastigmine in serum using solid phase extraction and high performance liquid chromatography coupled to UV detection technique for routine medical analysis. PHARMACOPSYCHIATRY, 40 (5): A137. p. 234. ISSN 0176-3679
Greiner, Christine and Wittmann, M. and Haen, E. (2007) Lamotrigine serum concentrations under valproate comedication: "Contraindication" or "Safe combination"? A case report. PHARMACOPSYCHIATRY, 40 (6). pp. 287-289. ISSN 0176-3679
Hausner, H. and Wittmann, M. and Poljansky, S. and Haen, E. and Spiessl, H. (2007) Sex differences in hospitalised depressed patients. EUROPEAN PSYCHIATRY, 22 (Suppl1). S67. ISSN 0924-9338
Hader, A. and Kirchheiner, J. and Jahner, T. and Haen, E. (2007) Therapeutic drug monitoring in psychiatry genotyping amends clinical pharmacological comments. PHARMACOPSYCHIATRY, 40 (5): A186. p. 244. ISSN 0176-3679
Hader, A. and Koestlbacher, A. and Kirchheiner, J. and Melchner, D. and Haen, E. (2007) Therapeutic drug monitoring in psychiatry: clinical pharmacological comments and genotyping as pharmacovigilance tools. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 101 (5). p. 385. ISSN 1742-7835
Fischer-Barnicol, David and Koch, H. and Wolff, K. E. and Hartmann, G. K. and Haen, E. and Klein, H. E. and Lanquillon, S. (2007) Women tolerate antipsychotics better than men? A analysis of different common treatment of extrapyramidal symptoms for women and Men under antipsychotic therapy. NERVENARZT, 78 (Suppl2). p. 358. ISSN 0028-2804
Greiner, C. and Haen, E. (2006) Clinical pharmacological comments are essential for therapeutic drug monitoring (TDM). NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 372 (Suppl1). p. 145. ISSN 0028-1298
Melzer, M. and Worek, F. and Ibach, B. and Haen, E. (2006) Determination of kinetic constants of carbamylation and decarbamylation of human cholinesterases by rivastigmine. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 372 (Suppl1). p. 148. ISSN 0028-1298
Greiner, C. and Bader, W. and Melchner, D. and Haen, E. (2006) Drug monitoring of lamotrigine increases drug safety of concomitant use with valproate. DRUG SAFETY, 29 (10). p. 942. ISSN 0114-5916
Wittmann, M. and Gsell, W. and Nonenmacher, T. and Haen, E. (2006) Neuroleptic-induced hyperprolactinaemia - a case series. DRUG SAFETY, 29 (10): 105. p. 1014. ISSN 0114-5916
Mueller, W. E. and Haen, E. and Fritze, J. and Ruether, Eckart and Laux, Gerd and Bauer, M. and Moeller, H.-J. (2004) Selective serotonin and norepinephrine reuptake inhibitors (SSNRI) - antidepressants with a dual mode of action. PSYCHOPHARMAKOTHERAPIE, 11 (3). pp. 71-75. ISSN 0944-6877
Conference or Workshop Item
Brandl, R. and Jahner, T. and Beck, S. and Melchner, D. and Haen, E. (2009) ASSAY TO STUDY DRUG-DRUG INTERACTIONS BETWEEN CITALOPRAME AND ADDITIONALLY PRESCRIBED PSYCHOTROPIC DRUGS IN HUMAN LIVER MICROSOMES. In: Annual Meeting of the German Clinical Pharmacologists, October 21-24, 2009, Heidelberg, Germany.
Hader, A. and Haen, E. (2009) CASE REPORT: NON-SUFFICIENT CONCENTRATIONS OF OLANZAPINE IN A PATIENT UNDER OLANZAPINE MELTING TABLETS. In: Annual Meeting of the German Clinical Pharmacologists, October 21-24, 2009, Heidelberg, Germany.
Haen, E. and Greiner, C. U. (2008) Dose-related reference ranges for therapeutic drug monitoring in human blood specimens. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Wittmann, M. and Haen, E. (2008) Drug treatment of personality disorders - A valuation date analysis from the AGATE group. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Haen, E. and Kaiser, M. C. and Greiner, C. U. (2008) Drugs used in the treatment of schizophrenia over the years 2000 to 2006 - an analysis of the AGATE data bases. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Koeber, R. and Kluenemann, H. H. and Melchner, D. and Haen, E. (2008) Implementation of a new cost-effective HPLC/UV-system for therapeutic drug monitoring of antidementia drugs in medical routine analysis shown by the example of galantamine (Reminyl (R)). In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Pfuhlmann, B. and Greiner, C. U. and Riederer, P. and Deckert, J. and Haen, E. and Hiemke, C. (2008) Influence of age, gender, smoking habits and comedication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Koestlbacher, A. and Haen, E. (2008) Konbest - A web-based Laboratory Information management System (LIMS) for TDM-Laboratories. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Greiner, C. U. and Nazirizadeh, Y. and Hiemke, C. and Haen, E. (2008) Lamotrigine in bipolar disorders - Is there an effective therapeutic reference concentration? In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Greiner, C. U. and Haen, E. (2008) Safety aspects of antipsychotics. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Wittmann, M. and Greiner, C. U. and Bader, W. and Koestlbacher, A. and Hess, R. and Haen, E. (2008) Therapeutic Drug Monitoring (TDM) of quetiapine in clinical practise. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Wittmann, M. and Greiner, C. U. and Haen, E. (2008) Therapeutic drug monitoring of aripiprazole in clinical practice. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Hader, A. and Kirchheiner, J. and Melchner, D. and Loehr, A. and Haen, E. (2008) Validation of PCR-methods in a TDM-laboratory. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Wagner, M. and Haen, E. (2008) A post-marketing observational study investigating efficacy and tolerability of escitalopram in clinical everyday practice. In: 5th Regensburg Symposium on Clinical Pharmacology of Therapeutical Drug Monitoring/8th Workshop of the TDM Workgroup of AGNP, September 24-27, 2008, Regensburg, Germany.
Bader, W. and Haen, E. (2004) Development of a method for the determination of risperidone and its 9-hydroxy-metabolite in human serum, using HPLC and electrochemical detection. In: 45th Spring Meeting Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, March 09-11, 2004, Mainz, GERMANY.
Haen, E. and Klein, H. E. (2004) The use of psychopharmaca in the treatment of schizophrenia in psychiatric hospitals. In: 45th Spring Meeting Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, March 09-11, 2004, Mainz, GERMANY.
Lanquillon, S. and Fischer-Barnicol, D. and Haen, E. and Hajak, G. and Klein, H. E. (2003) Benefit of modern antipsychotics still withheld from forensic patients. In: 23rd Symposium of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Oct 08-10, 2003, Munich, Germany.
Haen, E. (2003) Changes in the effectiveness of drugs in elderly people. In: 23rd Symposium of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Oct 08-10, 2003, Munich, Germany.
Sand, P. and Dobmeier, M. and Eichhammer, P. and Hajak, G. and Dallinger, P. and Haen, E. (2003) Gender effects in olanzapine metabolism. In: 23rd Symposium of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Oct 08-10, 2003, Munich, Germany.
Fischer-Barnicol, D. and Lanquillon, S. and Reischle, E. and Haen, E. and Hajak, G. and Klein, H. E. (2003) Perazine - the atypical side of an conventional antipsychotic. In: 23rd Symposium of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Oct 08-10, 2003, Munich, Germany.
Ibach, B. and Kerchlango, A. and Haen, E. and Klein, H. E. (2003) Psychopharmacotherapy and adverse drug effects in old age psychiatry. In: 23rd Symposium of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Oct 08-10, 2003, Munich, Germany.
Haen, E. and Dobmeier, M. and Spiessl, H. and Melchner, D. and Nonenmacher, T. (2002) TDM of clozapine and olanzapine: Undesired drug effects, compliance and pharmacoeconomy. In: 5th Workshop of AGNP Therapeutic Drug Monitoring of Psychotropic Drugs, July 4 - 5, 2002, Magdeburg, Germany.
Dobmeier, M. and Haen, E. and Spiessl, H. and Klein, H. (2001) How clinically useful is therapeutic drug monitoring of neuroleptic drugs? In: 42nd Spring Meeting Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, March 13-15, 2001, Mainz.
Haen, E. and Spindler, P. and Klein, H. E. (2001) The use of psychopmarmaca in the treatment of depression in Bavarian psychiatric hospitals. In: 42nd Spring Meeting Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, March 13-15, 2001, Mainz.
Haen, E. and Buchberger, M. and Hesse, A. (2000) Antiallergic effects of antidepressants. In: Regionaler Forschungskongress der Psychiatrischen Fachkrankenhäuser Bayerns, 28.-29.10.1999, Irsee.
Other
Hiemke, C. and Bergemann, N. and Clement, H. W. and Conca, A. and Deckert, J. and Domschke, K. and Eckermann, G. and Egberts, K. and Gerlach, M. and Greiner, C. and Gruender, G. and Haen, E. and Havemann-Reinecke, U. and Hefner, G. and Helmer, R. and Janssen, G. and Jaquenoud, E. and Laux, G. and Messer, T. and Moessner, R. and Mueller, M. J. and Paulzen, M. and Pfuhlmann, B. and Riederer, P. and Saria, A. and Schoppek, B. and Schoretsanitis, G. and Schwarz, M. and Silva Gracia, M. and Stegmann, B. and Steimer, W. and Stingl, J. C. and Uhr, M. and Ulrich, S. and Unterecker, S. and Waschgler, R. and Zernig, G. and Zurek, G. and Baumann, P. (2018) Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. GEORG THIEME VERLAG KG, STUTTGART.
Knorr, R. and Schoellkopf, J. and Haen, E. (2018) Neuroleptic malignant syndrome. SPRINGER, NEW YORK.
Schoretsanitis, G. and Haen, E. and Hiemke, C. and Gruender, G. and Paulzen, M. (2017) Pharmacokinetic differences for risperidone between genders. ELSEVIER SCIENCE BV, AMSTERDAM.
Schoretsanitis, G. and Haen, E. and Hiemke, C. and Gruender, G. and Paulzen, M. (2017) Pharmacokinetics to rediscover psychotropics; the case of risperidone. ELSEVIER SCIENCE BV, AMSTERDAM.
Wolf, L. and Nothdurfter, C. and Kreutz, M. and Haen, E. and Rupprecht, R. (2014) TSPO (18 kDa) - a new pharmacological drug target in anxiety and depression therapy. ELSEVIER SCIENCE BV, AMSTERDAM.
Ben Omar, N. and Wenzel-Seifert, K. and Haen, E. (2013) Age-Dependency of Psychotropic Drug-Induced Anticholinergic Adverse Events: Analysis of the Data Bank of the Pharmacovigilance System AGATE. SPRINGER, NEW YORK.
Wenzel-Seifert, K. and Haen, E. (2013) Therapeutic Drug Monitoring of Citalopram and Escitalopram: Analysis of Data from Routine Therapeutic Drug Monitoring (TDM). SPRINGER, NEW YORK.
